MD Anderson 2020 Updates on Biomarkers in Melanoma: Why Do We Need Liquid Biomarkers? Are CTSs/CMCs Prognostic? Can We Use Them to Guide Adjuvant Therapy Decisions?

89 views
December 1, 2020
Comments 0
Login to view comments. Click here to Login